Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of actionin vitroandin vivo (Q27649983)

0 references

F Burke

0 references

M Warnock

0 references

Y Zhou

0 references

J Sweigart

0 references

A Chen

0 references

D Ricketts

0 references

B R Lucchesi

0 references

Z Chen

0 references

E Di Cera

0 references

J Hilfinger

0 references

J S Kim

0 references

H I Mosberg

0 references

A H Schmaier

Journal of Thrombosis and Haemostasis

0 references

language of work or name

1 reference

May 2008

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

837-45

0 references

cites work

Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Mechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombin

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Cathepsin G activates protease-activated receptor-4 in human platelets

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

The refined 1.9-Å X-ray crystal structure of d-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: Structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

The CCP4 suite: programs for protein crystallography

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Stereochemical quality of protein structure coordinates

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Developing peptide inhibitors to thrombin activation of platelets from bradykinin analogs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652574

Prasugrel versus clopidogrel in patients with acute coronary syndromes

29 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02937.X

Mapping the interaction of bradykinin 1-5 with the exodomain of human protease activated receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02937.X

Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02937.X

Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02937.X

Molecular dissection of Na+ binding to thrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02937.X

Processing of X-ray diffraction data collected in oscillation mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02937.X

Plasmin Desensitization of the PAR1 Thrombin Receptor: Kinetics, Sites of Truncation, and Implications for Thrombolytic Therapy†

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02937.X

Establishing the inhibitory effects of bradykinin on thrombin

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18315550

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18315550

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18315550